TITLE

CD4 T cells in tumor immunity

AUTHOR(S)
Gerloni, Mara; Zanetti, Maurizio
PUB. DATE
June 2005
SOURCE
Springer Seminars in Immunopathology;Jun2005, Vol. 27 Issue 1, p37
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
T cell immunity is the key to protective immune responses against tumors. Traditionally, this function has been ascribed to CD8 T lymphocytes with cytotoxic activity, which are restricted by MHC class I molecules. In recent years the realization that CD4 T cells can also play a relevant role in protective anti-tumor responses has received growing attention. Here we will discuss the role of MHC class II-restricted T cells in response to, and in the regulation of, tumor antigens. Emphasis will be placed on four areas: (1) the role of CD4 T cell immunity in tumor protection in animal models and putative mode of action, (2) tumor antigens recognized by human CD4 T cells, (3) the cooperation between two CD4 T cells of different specificity as a new way to jump start the response against sub-immunogenic determinants of tumor antigens in a tolerant environment, and (4) the negative impact of regulatory CD4 T cells on anti-tumor T cell responses. By drawing attention to these four areas, it is our intention to provide the reader with a comprehensive view of issues of contemporary importance for this field, in the expectation that the information will help a better design of therapeutic cancer vaccines.
ACCESSION #
17738897

 

Related Articles

  • Spatial separation of the processing and MHC class I loading compartments for cross-presentation of the tumor-associated antigen HER2/ neu by human dendritic cells. Baleeiro, Renato B; Rietscher, René; Diedrich, Andrea; Czaplewska, Justyna A; Lehr, Claus-Michael; Scherließ, Regina; Hanefeld, Andrea; Gottschaldt, Michael; Walden, Peter // OncoImmunology;Nov2015, Vol. 4 Issue 11, pN.PAG 

    Cross-presentation is the process by which professional antigen presenting cells (APCs) (B cells, dendritic cells (DCs) and macrophages) present endocytosed antigens (Ags) via MHC-I to CD8+T cells. This process is crucial for induction of adaptive immune responses against tumors and infected...

  • In situ detection of antigen-specific T cells in cryo-sections using MHC class I tetramers after dendritic cell vaccination of melanoma patients. Vries, I. J. M.; Bernsen, M. R.; van Geloof, W. L.; Scharenborg, N. M.; Lesterhuis, W. J.; Rombout, P. D. M.; Van Muijen, G. N. P.; Figdor, C. G.; Punt, C. J. A.; Ruiter, D. J.; Adema, G. J. // Cancer Immunology, Immunotherapy;Oct2007, Vol. 56 Issue 10, p1667 

    Application of tetrameric MHC class I-peptide complexes has significantly improved the monitoring of antigen-specific T cell immune responses in mouse models as well as in clinical studies. Especially MHC class I tetramer analysis of tumor-specific T cells in suspension or on thick vibratome...

  • Defining MHC class II T helper epitopes for WT1 tumor antigen. Kobayashi, Hiroya; Nagato, Toshihiro; Aoki, Naoko; Sato, Keisuke; Kimura, Shoji; Tateno, Masatoshi; Celis, Esteban // Cancer Immunology, Immunotherapy;Jul2006, Vol. 55 Issue 7, p850 

    The product of Wilms‘ tumor gene 1 (WT1) is overexpressed in diverse human tumors, including leukemia, lung and breast cancer, and is often recognized by antibodies in the sera of patients with leukemia. Since WT1 encodes MHC class I-restricted peptides recognized by cytotoxic T...

  • The 'chop-and-change' of MHC class I assembly. Elliott, Tim // Nature Immunology;Jan2006, Vol. 7 Issue 1, p7 

    This article states that the CD8+ T cell recognition of peptides presented by major histocompatibility complex class I molecules is essential for effective antiviral and antitumor immune responses. Cytotoxic T lymphocytes scan a micro-array of peptide-major histocompatibility complex class I...

  • The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible “hard” lesions. Garrido, Federico; Algarra, Ignacio; García-Lora, Angel M. // Cancer Immunology, Immunotherapy;Oct2010, Vol. 59 Issue 10, p1601 

    The discovery of tumor antigens recognized by T lymphocytes has stimulated the development of a variety of cancer treatment protocols aimed at enhancing antitumor-specific T cell responses and tumor rejection. However, immunotherapy-mediated regression of established tumors and clearly positive...

  • IL-6, but not IFN-γ, triggers apoptosis and inhibits in vivo growth of human malignant T cells on STAT3 silencing. Regis, G.; Icardi, L.; Conti, L.; Chiarle, R.; Piva, R.; Giovarelli, M.; Poli, V.; Novelli, F. // Leukemia (08876924);Nov2009, Vol. 23 Issue 11, p2102 

    STAT1 and STAT3 are the main mediators of the signaling of interferons (IFNs) and of gp130 cytokines, respectively. Neoplastic T lymphocytes frequently become resistant to the IFN-γ/STAT1 apoptotic pathway, often because of the downregulation of the IFN-γR2 receptor chain. Many studies...

  • Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes. Vigneron, Nathalie; Van den Eynde, Benoît // Cellular & Molecular Life Sciences;May2011, Vol. 68 Issue 9, p1503 

    The molecular definition of tumor antigens recognized by cytolytic T lymphocytes (CTL) started in the late 1980s, at a time when the MHC class I antigen processing field was in its infancy. Born together, these two fields of science evolved together and provided each other with critical...

  • Multifaceted roles of MHC class I and MHC class I?like molecules in T cell activation. Ugolini, Sophie; Vivier, Eric // Nature Immunology;Mar2001, Vol. 2 Issue 3, p198 

    Presentation of the multifaceted roles of the major histocompatibility complex (MHC) class I and MHC class I-like molecules in T cell activation. Provision of costimulatory signal and augmentation of the cytotoxic response of MHC through the engagement of NKG2D on CMV specific aα Bβ...

  • Detection and Characterization of Cellular Immune Responses Using Peptide --MHC Microarrays. Soen, Yoav; Chen, Daniel S.; Kraft, Daniel L.; Davis, Mark M.; Brown, Patrick O. // PLoS Biology;Dec2003, Vol. 1 Issue 3, p429 

    The detection and characterization of antigen-specific T cell populations is critical for understanding the development and physiology of the immune system and its responses in health and disease. We have developed and tested a method that uses arrays of peptide-MHC complexes for the rapid...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics